These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37803082)
21. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
22. Research on psychedelics moves into the mainstream. Morris K Lancet; 2008 May; 371(9623):1491-2. PubMed ID: 18459186 [No Abstract] [Full Text] [Related]
23. The Emerging Field of Psychedelic Psychotherapy. Barber GS; Aaronson ST Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571 [TBL] [Abstract][Full Text] [Related]
24. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review. Szafoni S; Więckiewicz G; Pudlo R; Gorczyca P; Piegza M Psychiatr Pol; 2022 Aug; 56(4):823-836. PubMed ID: 37074831 [TBL] [Abstract][Full Text] [Related]
25. Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation. Curran HV; Nutt D; de Wit H Psychopharmacology (Berl); 2018 Feb; 235(2):373-375. PubMed ID: 29445838 [No Abstract] [Full Text] [Related]
26. Turn on and tune in to evidence-based psychedelic research. Sessa B Lancet Psychiatry; 2015 Jan; 2(1):10-2. PubMed ID: 26359597 [No Abstract] [Full Text] [Related]
27. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Mitchell JM; Bogenschutz M; Lilienstein A; Harrison C; Kleiman S; Parker-Guilbert K; Ot'alora G M; Garas W; Paleos C; Gorman I; Nicholas C; Mithoefer M; Carlin S; Poulter B; Mithoefer A; Quevedo S; Wells G; Klaire SS; van der Kolk B; Tzarfaty K; Amiaz R; Worthy R; Shannon S; Woolley JD; Marta C; Gelfand Y; Hapke E; Amar S; Wallach Y; Brown R; Hamilton S; Wang JB; Coker A; Matthews R; de Boer A; Yazar-Klosinski B; Emerson A; Doblin R Nat Med; 2021 Jun; 27(6):1025-1033. PubMed ID: 33972795 [TBL] [Abstract][Full Text] [Related]
29. MDMA and PTSD treatment: "PTSD: From novel pathophysiology to innovative therapeutics". Sessa B Neurosci Lett; 2017 May; 649():176-180. PubMed ID: 27394687 [TBL] [Abstract][Full Text] [Related]
30. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? Feduccia AA; Mithoefer MC Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):221-228. PubMed ID: 29524515 [TBL] [Abstract][Full Text] [Related]
31. The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder. Rothbaum BO; Maples-Keller JL Neuropsychopharmacology; 2023 Jan; 48(1):255-256. PubMed ID: 35859012 [No Abstract] [Full Text] [Related]
32. Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine. Fattore L; Piva A; Zanda MT; Fumagalli G; Chiamulera C Psychopharmacology (Berl); 2018 Feb; 235(2):433-445. PubMed ID: 29178010 [TBL] [Abstract][Full Text] [Related]
33. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder. Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611 [TBL] [Abstract][Full Text] [Related]
34. Why MDMA therapy for alcohol use disorder? And why now? Sessa B Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911 [TBL] [Abstract][Full Text] [Related]
35. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis. Smith KW; Sicignano DJ; Hernandez AV; White CM J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874 [TBL] [Abstract][Full Text] [Related]
36. MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. Brewerton TD; Wang JB; Lafrance A; Pamplin C; Mithoefer M; Yazar-Klosinki B; Emerson A; Doblin R J Psychiatr Res; 2022 May; 149():128-135. PubMed ID: 35272210 [TBL] [Abstract][Full Text] [Related]
37. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. Brewerton TD; Lafrance A; Mithoefer MC Med Hypotheses; 2021 Jan; 146():110367. PubMed ID: 33203569 [TBL] [Abstract][Full Text] [Related]
38. The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD. Nicholas CR; Wang JB; Coker A; Mitchell JM; Klaire SS; Yazar-Klosinski B; Emerson A; Brown RT; Doblin R Drug Alcohol Depend; 2022 Apr; 233():109356. PubMed ID: 35286849 [TBL] [Abstract][Full Text] [Related]
39. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder. Amoroso T J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955 [TBL] [Abstract][Full Text] [Related]